Wang A, Since M, Dallemagne P, Rochais C. Implication of Central β2 Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease. Arch Pharm (Weinheim). 2025 Apr;358(4):e2400750. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics